Camp4 Therapeutics (CAMP) Receivables - Other (2023 - 2025)

Camp4 Therapeutics recorded quarterly Receivables - Other of $400000.0 in Q3 2025, up 33.33% quarter-over-quarter from $300000.0 in Q2 2025, and up 300.0% year-over-year from $100000.0 in Q3 2024.

Camp4 Therapeutics' Receivables - Other history runs 3 years deep, the most recent figure standing at $400000.0 for Q3 2025.

  • In Q3 2025, Receivables - Other rose 300.0% year-over-year to $400000.0; the TTM figure through Sep 2025 stood at $400000.0 (up 300.0% YoY), while the FY2024 annual figure was $100000.0, changed 0.0% from the prior year.
  • Receivables - Other came in at $400000.0 for Q3 2025 at Camp4 Therapeutics, up from $300000.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $400000.0 in Q3 2025 to a low of $100000.0 in Q4 2023.
  • A 3-year average of $183333.3 and a median of $100000.0 in 2023 frame the typical range for Receivables - Other.
  • Across the five-year window, Receivables - Other changed 0.0% in 2024 and surged 300.0% in 2025, its largest moves.
  • Camp4 Therapeutics' Receivables - Other stood at $100000.0 in 2023, then changed by 0.0% to $100000.0 in 2024, then soared by 300.0% to $400000.0 in 2025.
  • According to Business Quant data, Receivables - Other over the past three periods registered $400000.0, $300000.0, and $100000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Camp4 Therapeutics 245.89 Mn 245.89 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 400,000.00
Sep 30, 2025 400,000.00
Jun 30, 2025 300,000.00
Jun 30, 2025 300,000.00
Mar 31, 2025 100,000.00
Mar 31, 2025 100,000.00
Dec 31, 2024 100,000.00
Dec 31, 2024 100,000.00
Sep 30, 2024 100,000.00
Sep 30, 2024 100,000.00
Dec 31, 2023 100,000.00
Dec 31, 2023 100,000.00